Efficacy and Safety of Ivermectin Against Dengue Infection

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.

ClinicalTrials.gov Identifier: NCT02045069

Recruitment Status : Unknown

Verified October 2015 by Mahidol University.
Recruitment status was: Recruiting

First Posted : January 24, 2014

Last Update Posted : November 1, 2015

View this study on the modernized ClinicalTrials.gov

Sponsor:

Collaborator:

Ministry of Health, Thailand

Information provided by (Responsible Party):

Mahidol University

No Study Results Posted on ClinicalTrials.gov for this Study

About Study Results Reporting on ClinicalTrials.gov

Recruitment Status :	Unknown
Estimated Primary Completion Date :	February 2016
Estimated Study Completion Date :	March 2016

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):

Ooi EE. Repurposing Ivermectin as an Anti-dengue Drug. Clin Infect Dis. 2021 May 18;72(10):e594-e595. doi: 10.1093/cid/ciaa1341. No abstract available.

To Top